Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Zhejiang University. Science. B ; (12): 22-28, 2009.
Artigo em Inglês | WPRIM | ID: wpr-335405

RESUMO

Interleukin-5 (IL-5) accompanies the development of airway inflammation and hyperresponsiveness through the activation of eosinophils. Therefore, interference of IL-5 expression in lung tissue seems to be an accepted approach in asthma therapy. In this study, we designed a small interfering RNA (siRNA) to inhibit the expression of IL-5. The siRNAs against IL-5 were constructed in a lentivirus expressing system, and 1.5x10(6) IFU (inclusion-forming unit) lentiviruses were administered intratracheally to ovalbumin (OVA)-sensitized murine asthmatic models. Our results show that lentivirus-delivered siRNA against IL-5 efficiently inhibited the IL-5 messenger ribonucleic acid (mRNA) expression and significantly attenuated the inflammation in lung tissue. Significant decrease of eosinophils and inflammatory cells were found in peripheral blood, bronchoalveolar lavage fluid (BALF), and lung tissue. In addition, significant inhibition of airway hyperresponsiveness (AHR) was found in the mice treated with siRNA against IL-5. These observations demonstrate that siRNA delivered by means of the lentivirus system is possibly an efficacious therapeutic approach for asthma.


Assuntos
Animais , Humanos , Masculino , Camundongos , Asma , Alergia e Imunologia , Hiper-Reatividade Brônquica , Alergia e Imunologia , Modelos Animais de Doenças , Terapia Genética , Métodos , Interleucina-5 , Genética , Alergia e Imunologia , Camundongos Endogâmicos BALB C , Pneumonia , Alergia e Imunologia , RNA , Usos Terapêuticos , Resultado do Tratamento
2.
Chinese Medical Journal ; (24): 1517-1522, 2007.
Artigo em Inglês | WPRIM | ID: wpr-280395

RESUMO

<p><b>BACKGROUND</b>Eosinophils are highly related to allergic asthma inflammation. Interleukin (IL)-5 is the major chemokine of eosinophils, inhibition of the activity of IL-5 thus seems to be a potential approach to asthma therapy. The current study was performed to determine whether a recombinant human IL-5 protein as a xenogeneic vaccine has the capability of inducing anti-asthma activities.</p><p><b>METHODS</b>Recombinant human IL-5 was used as a protein vaccine. Mouse asthma model was established to observe the anti-asthma activities. Lung histology was observed; eosinophils in blood and bronchoalveolar lavage were stained and counted. Airway hyperresponsiveness was determined by whole body plethysmograph. Antibody characters and cytokines were detected with enzyme linked immunosorbent assay (ELISA) and Western blot assay.</p><p><b>RESULTS</b>Vaccination with recombinant human IL-5 protein as vaccine significantly reduced airway inflammation and airway hyperresponsiveness, and shifted the cytokine production from Th2 (IL-4) to Th1 (INF-gamma) in mice allergic-asthma model. Immunization with recombinant human IL-5 protein vaccine bypassed the immunological tolerance and induced production of polyclonal antibodies that were cross-reactive with murine IL-5.</p><p><b>CONCLUSIONS</b>Active immunization with xenogeneic homologous IL-5 may be a possible therapeutic approach to the treatment of asthma and potentially of other eosinophilic disorders.</p>


Assuntos
Animais , Masculino , Camundongos , Asma , Terapêutica , Linfócitos B , Alergia e Imunologia , Hiper-Reatividade Brônquica , Citocinas , Modelos Animais de Doenças , Interleucina-5 , Alergia e Imunologia , Camundongos Endogâmicos BALB C , Proteínas Recombinantes , Alergia e Imunologia , Células Th2 , Alergia e Imunologia , Vacinação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA